News Outlets Discuss Efforts To Develop, Manufacture Vaccines, Therapeutics For Novel Coronavirus

AFP/France 24: Israel begins coronavirus vaccine trials (11/1).

Bloomberg: U.K. Accelerates Reviews of Pfizer and Astra-Oxford Vaccines (Ring, 10/30).

Financial Times: U.K. plans to use AI to process adverse reactions to Covid vaccines (Gross, 11/1).

The Guardian: ‘It’s possible’: the race to approve a Covid vaccine by Christmas (Boseley, 10/20).

Reuters: J&J plans to test its COVID-19 vaccine in ages 12-18 soon (Erman, 10/30).

Reuters: Can solar fridges helping vaccinate African children work for COVID-19? (Fleming, 10/31).

STAT: Antibody drugs seem to work. But the virus is moving faster than we can make them (Herper, 10/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.